Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
System1 A | SST | Nov 19, 2024 | 0.97 | +2.69 |
T Stamp A | IDAI | Nov 19, 2024 | 0.20 | +4.19 |
T-Mobile US | TMUS | Nov 19, 2024 | 233.20 | -1.62 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Nov 19, 2024 | 41.72 | +1.19 |
T. Rowe Price Dividend Growth ETF | TDVG | Nov 19, 2024 | 40.68 | -0.22 |
T. Rowe Price Equity Income ETF | TEQI | Nov 19, 2024 | 42.49 | -0.54 |
T. Rowe Price Group | TROW | Nov 19, 2024 | 117.95 | -0.60 |
T. Rowe Price Growth Stock ETF | TGRW | Nov 19, 2024 | 39.39 | +1.18 |
T2 Biosystems | TTOO | Nov 19, 2024 | 0.48 | -5.29 |
Taboola.com | TBLA | Nov 19, 2024 | 3.15 | +0.64 |
Tactile Systems Technology | TCMD | Nov 19, 2024 | 15.77 | -0.06 |
Taitron Components A | TAIT | Nov 19, 2024 | 2.64 | -4.69 |
Taiwan Fund | TWN | Nov 19, 2024 | 43.19 | +0.35 |
Taiwan Index MSCI Ishares | EWT | Nov 19, 2024 | 54.21 | +1.14 |
Taiwan Semiconductor Manufacturing ADR | TSM | Nov 19, 2024 | 189.67 | +1.17 |
Take-Two Interactive Software | TTWO | Nov 19, 2024 | 186.01 | +1.68 |
Takeda Pharmaceutical ADR | TAK | Nov 19, 2024 | 13.62 | +0.67 |
TAL Education Group ADR | TAL | Nov 19, 2024 | 9.91 | -0.40 |
Talen Energy | TLN | Nov 19, 2024 | 214.70 | +3.47 |
Talis Biomedical | TLIS | Nov 19, 2024 | 4.38 | 0.00 |
Talkspace | TALK | Nov 19, 2024 | 3.09 | +3.34 |
Talos Energy | TALO | Nov 19, 2024 | 11.03 | -3.33 |
Talphera | TLPH | Nov 19, 2024 | 0.67 | -1.43 |
Tamboran Resources | TBN | Nov 19, 2024 | 18.66 | -0.64 |
Tandem Diabetes Care | TNDM | Nov 19, 2024 | 27.87 | -3.09 |
Tanger | SKT | Nov 19, 2024 | 36.51 | +1.14 |
Tango Therapeutics | TNGX | Nov 19, 2024 | 3.85 | +6.94 |
Tantech | TANH | Nov 19, 2024 | 0.16 | -0.70 |
Taoping | TAOP | Nov 19, 2024 | 0.36 | -1.88 |
Tapestry | TPR | Nov 19, 2024 | 55.62 | -1.64 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.